BOM Brabant Ventures is an incubator and growth accelerator with over 35 years of experience, dedicated to supporting ambitious companies in the Brabant region. The organization provides knowledge and risk capital to facilitate the growth of startups and scaleups, focusing on key industries such as High Tech Systems and Materials, Agrofood, Biobased Economy, Life Sciences and Medtech, Maintenance, and Supply Chain. Through its expertise, BOM Brabant Ventures aims to foster sustainable development and innovation within these sectors, ensuring the long-term success of its portfolio companies.
SamanTree Medical SA is a Swiss company specializing in the development of innovative medical microscopy devices aimed at enhancing cancer treatment and surgical outcomes. Founded in 2014 and based in Ecublens, the company focuses on micro-optics-based digital microscopy systems that provide an extensive field of view for various applications, including research, diagnostics, and surgery. Its flagship product, a surgical digital microscope, enables real-time visualization of cellular structures within living tissue, facilitating precise assessment of tumor margins. This technology allows surgeons to achieve full margin control and make informed decisions during procedures, ultimately improving resection accuracy, reducing re-operation rates, and decreasing overall procedure costs. By enabling immediate visualization of cancerous cells during surgery, SamanTree Medical's devices significantly enhance patient care and outcomes in cancer surgery.
Microsure
Series B in 2023
Microsure is a medical device company based in Eindhoven, The Netherlands, founded in 2014. It specializes in developing innovative solutions for microsurgery, a field that operates at the limits of physical capabilities. The company's flagship product is a motion stabilizer system designed specifically for microsurgeons, which enhances surgical precision by filtering out tremors and providing exceptional control during procedures. This technology allows for hybrid microsurgical procedures that enable surgeons to utilize their own instruments, thereby reducing costs for hospitals. The Microsure motion stabilizer has demonstrated its effectiveness in clinical trials, including successful operations for lymphedema. By improving the quality of microsurgical procedures, the company aims to expand treatment options for patients and facilitate the development of new, highly accurate surgical techniques.
Sirius Medical
Series B in 2023
Sirius Medical helps improve healthcare for cancer patients by developing medical devices that aid in surgical treatment. Their objective is to create intuitive and accurate gadgets that allow surgeons and radiologists to provide the finest treatment. Sirius Perception uses audio and visual feedback to provide real-time, directional advice for pinpointing tumors
Scailable
Seed Round in 2022
Scailable is a technology company that offers a management platform designed for developers to create and manage plug-and-play edge artificial intelligence (AI) solutions at scale. Their platform facilitates efficient deployment, monitoring, and governance of AI and machine learning models across various environments, including cloud, browser, and edge devices, while requiring minimal memory. By integrating their AI management platform directly into continuous deployment pipelines, Scailable enables clients to build custom AI model management interfaces, allowing for secure and modular access to AI services that can operate fully locally.
STENTiT
Seed Round in 2022
STENTiT is a medical device company that emerged from the Eindhoven University of Technology in the Netherlands, specializing in regenerative endovascular implants. The company develops biodegradable stents aimed at restoring arteries by promoting a natural healing response. These implants facilitate the circulation of blood cells that replace the stent with new vascular tissue, effectively restoring the artery from within. This innovative approach enables healthcare professionals to treat patients suffering from cardiovascular diseases more effectively.
Sirius Medical
Series A in 2021
Sirius Medical helps improve healthcare for cancer patients by developing medical devices that aid in surgical treatment. Their objective is to create intuitive and accurate gadgets that allow surgeons and radiologists to provide the finest treatment. Sirius Perception uses audio and visual feedback to provide real-time, directional advice for pinpointing tumors
Ctrlchain
Seed Round in 2021
CtrlChain focuses on enhancing logistics management through its online software solutions, which cater to both regular and urgent shipments. The company aims to simplify operations for shippers and carriers by offering centralized systems that reduce manual processes and operational costs. Its software features include live tracking, order history, quick booking capabilities, and instant courier availability. By optimizing transport capacity and promoting sustainability, CtrlChain enables businesses to ensure timely and secure delivery of packages. The overall goal is to improve profitability, visibility, and service levels within the logistics sector.
Scailable
Pre Seed Round in 2021
Scailable is a technology company that offers a management platform designed for developers to create and manage plug-and-play edge artificial intelligence (AI) solutions at scale. Their platform facilitates efficient deployment, monitoring, and governance of AI and machine learning models across various environments, including cloud, browser, and edge devices, while requiring minimal memory. By integrating their AI management platform directly into continuous deployment pipelines, Scailable enables clients to build custom AI model management interfaces, allowing for secure and modular access to AI services that can operate fully locally.
Orbisk
Seed Round in 2021
Orbisk is a developer of automated food waste monitoring equipment aimed at enhancing sustainability in the food system. The company provides hospitality organizations with a waste bin outfitted with a scale and a smart camera that employs artificial intelligence image recognition algorithms. This technology allows for the identification of food waste ingredients through images, enabling restaurants to accurately quantify the volumes of food they discard. By offering actionable insights through a user-friendly dashboard, Orbisk helps organizations identify and optimize inefficiencies in their food-providing processes, ultimately leading to significant reductions in wasted food and improvements in both sustainability and profitability.
Trabotyx
Seed Round in 2021
Trabotyx is a developer of robotic platforms aimed at automating labor-intensive tasks for farmers, particularly in the area of weeding. The company's technology focuses on organic crops that typically require manual weeding, providing single-row autonomous weeding robots that target weeds in the critical 1 to 5 centimeter zone near plants. Trabotyx's adaptable wheelbase design allows its robots to accommodate various field layouts, enabling inter and intra row weeding. By reducing the need for manual labor, Trabotyx assists farmers in lowering operational costs while promoting increased biodiversity and soil restoration.
Microsure
Series B in 2021
Microsure is a medical device company based in Eindhoven, The Netherlands, founded in 2014. It specializes in developing innovative solutions for microsurgery, a field that operates at the limits of physical capabilities. The company's flagship product is a motion stabilizer system designed specifically for microsurgeons, which enhances surgical precision by filtering out tremors and providing exceptional control during procedures. This technology allows for hybrid microsurgical procedures that enable surgeons to utilize their own instruments, thereby reducing costs for hospitals. The Microsure motion stabilizer has demonstrated its effectiveness in clinical trials, including successful operations for lymphedema. By improving the quality of microsurgical procedures, the company aims to expand treatment options for patients and facilitate the development of new, highly accurate surgical techniques.
Shypple
Series A in 2021
Shypple is a digital freight forwarder that specializes in optimizing global supply chains through advanced technology. The company is comprised of a team with extensive backgrounds in logistics, international trade, and forwarding, which drives their mission to streamline the process of booking, managing, and tracking freight shipments. Shypple's platform features a digital dashboard that serves as a central hub for information, enhancing collaboration among all stakeholders in the logistics process. By offering routing options, price comparisons from various carriers, and real-time shipment visibility, Shypple aims to improve accountability and efficiency in international trade while maintaining the personal service expected from traditional forwarders. This approach allows enterprises to navigate the complexities of global freight movement with greater ease and transparency.
Orbisk
Pre Seed Round in 2020
Orbisk is a developer of automated food waste monitoring equipment aimed at enhancing sustainability in the food system. The company provides hospitality organizations with a waste bin outfitted with a scale and a smart camera that employs artificial intelligence image recognition algorithms. This technology allows for the identification of food waste ingredients through images, enabling restaurants to accurately quantify the volumes of food they discard. By offering actionable insights through a user-friendly dashboard, Orbisk helps organizations identify and optimize inefficiencies in their food-providing processes, ultimately leading to significant reductions in wasted food and improvements in both sustainability and profitability.
Xyall
Series A in 2020
Xyall is a global innovator specializing in molecular pathology. The company has developed advanced tissue dissection technology aimed at automating and digitizing the tissue dissection workflow. This platform enhances accuracy in diagnostic results, scales effectively to meet demand, and reduces operational costs while minimizing the risk of cross-contamination. Additionally, it ensures traceability for each sample and test, allowing pathologists to obtain reliable molecular diagnostic test results in real-time. Through these innovations, Xyall contributes significantly to improving the efficiency and reliability of molecular diagnostics in healthcare.
Knowingo+
Seed Round in 2019
Knowingo provides live data and statistics on employees’ knowledge levels across different topics.
Citryll
Series A in 2019
Citryll is a private pharmaceutical company based in Oss, The Netherlands, founded in 2015. The company focuses on developing drugs aimed at treating autoimmune diseases and other human health conditions. Citryll's innovative approach involves the manipulation of the formation, function, and clearance of neutrophil extracellular traps (NETs) that are influenced by the protein citrullination pathway, specifically through the action of Peptidylarginine Deiminase (PAD) enzymes. This research supports medical professionals in addressing various serious conditions, including lupus, vasculitis, pulmonary fibrosis, rheumatoid arthritis, and organ damage resulting from sepsis.
DENS
Seed Round in 2019
Dutch Energy Systems focuses on innovative energy solutions, specifically hydrazine-based systems that generate hydrogen and electricity. Their technology offers a sustainable and emissions-free alternative to traditional diesel generators, making it particularly beneficial for heavy-duty vehicles and machinery in sectors such as agriculture and construction. The company’s generators convert hydrazine into hydrogen, which is then transformed into electricity, providing clients with a renewable and silent power source. This approach significantly reduces the reliance on fossil fuels and contributes to lowering emissions in industries that typically depend on diesel-powered equipment.
SamanTree Medical
Series A in 2019
SamanTree Medical SA is a Swiss company specializing in the development of innovative medical microscopy devices aimed at enhancing cancer treatment and surgical outcomes. Founded in 2014 and based in Ecublens, the company focuses on micro-optics-based digital microscopy systems that provide an extensive field of view for various applications, including research, diagnostics, and surgery. Its flagship product, a surgical digital microscope, enables real-time visualization of cellular structures within living tissue, facilitating precise assessment of tumor margins. This technology allows surgeons to achieve full margin control and make informed decisions during procedures, ultimately improving resection accuracy, reducing re-operation rates, and decreasing overall procedure costs. By enabling immediate visualization of cancerous cells during surgery, SamanTree Medical's devices significantly enhance patient care and outcomes in cancer surgery.
CytoSMART Technologies
Series B in 2019
Cytosmart is a Netherlands-based company founded in 2012 that specializes in developing innovative devices for laboratory use, particularly in the field of cell culture monitoring. The company offers a range of products, including the CytoSMART Lux2, CytoSMART Exact, and CytoSMART Omni, which are designed to facilitate cell counting and monitor cell culture growth. These devices leverage advanced technology and custom-built software, allowing researchers to efficiently oversee their experiments remotely, thus enhancing productivity and minimizing the need for physical presence in the lab. Cytosmart's client base includes prominent institutions such as Fontys, THM, Roche, the University of Oxford, EMBL, and the University of St Andrews.
Enpicom
Series A in 2019
Enpicom is a bioinformatics software company that specializes in supporting scientists in the biopharma and academic research sectors. The company offers innovative products and tailored solutions aimed at enhancing the discovery and development of new immunotherapies and vaccines. Enpicom's technology-agnostic, code-free software simplifies the management and analysis of immune repertoire sequencing data, allowing researchers to efficiently decode the immune system. By streamlining the antibody discovery process, Enpicom enables scientists to concentrate on their research and development efforts, ultimately contributing to advancements in human health.
Additive Industries
Debt Financing in 2019
Additive Industries B.V., founded in 2012 and based in Eindhoven, Netherlands, specializes in the design and manufacture of industrial metal additive manufacturing systems. The company aims to transition metal additive manufacturing from laboratory settings to practical applications in high-demand industrial markets. By offering a modular 3D printing system and an integrated information platform, Additive Industries enhances reproducibility, productivity, and flexibility in producing functional parts. Their technology is particularly beneficial for sectors such as aerospace, automotive, medical technology, and high-tech equipment, enabling the creation of lighter, more compact, and complex components with improved thermal performance. The company boasts a team of highly experienced engineers and professionals from the high-tech ecosystem in Eindhoven, further solidifying its position in the industry.
DegenRx B.V.
Series A in 2018
DegenRx is a biotech startup working on AAV-mediated gene therapy for CNS disorders like Parkinson's and Alzheimer's. They transmit genes to the brain that start the local synthesis of therapeutic antibodies using adeno-associated-viral vectors. Its goal is to discover and create treatments for neurodegenerative disorders so people can age longer and healthier.
CytoSMART Technologies
Series A in 2016
Cytosmart is a Netherlands-based company founded in 2012 that specializes in developing innovative devices for laboratory use, particularly in the field of cell culture monitoring. The company offers a range of products, including the CytoSMART Lux2, CytoSMART Exact, and CytoSMART Omni, which are designed to facilitate cell counting and monitor cell culture growth. These devices leverage advanced technology and custom-built software, allowing researchers to efficiently oversee their experiments remotely, thus enhancing productivity and minimizing the need for physical presence in the lab. Cytosmart's client base includes prominent institutions such as Fontys, THM, Roche, the University of Oxford, EMBL, and the University of St Andrews.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.